Concourse Financial Group Securities’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5390 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6275 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6266 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6285 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6283 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6215 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6084 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5941 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5726 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5720 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5537 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5519 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5415 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5420 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5275 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5104 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4960 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4831 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4635 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4508 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4496 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4436 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4229 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4419 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4358 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4235 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3951 |
|